SCHEMBL7312307

SCHEMBL7312307

CC(C)[C@H](NC(=O)OCc1cccnc1)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)OCc1cccnc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.58
CA2 P00918 1/20 0.55
CTSD P07339 3/20 0.53
MEN1 O00255 1/20 0.52
SLC22A2 O15244 1/20 0.52
SLC22A1 O15245 1/20 0.52
ABCC3 O15438 1/20 0.52
ABCC4 O15439 1/20 0.52
MLNR O43193 1/20 0.52
NR1I2 O75469 1/20 0.52
SLCO2B1 O94956 1/20 0.52
ABCB11 O95342 1/20 0.52
ALDH1A1 P00352 1/20 0.52
PGR P06401 1/20 0.52
ABCB1 P08183 1/20 0.52
HTR1A P08908 1/20 0.52
ADRA2A P08913 1/20 0.52
ADORA3 P0DMS8 1/20 0.52
CYP2D6 P10635 1/20 0.52
MAPT P10636 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7298935 0.96 CYP3A4 (0.56) CYP3A4CA2CTSDMEN1SLC22A2
SCHEMBL13240259 0.93 CA2 (0.62) CYP3A4CA2CTSDMEN1SLC22A2
SCHEMBL2771252 0.93 CA2 (0.62) CYP3A4CA2CTSDMEN1SLC22A2
SCHEMBL8124341 0.91 CYP3A4 (0.52) CYP3A4CA2CTSDMEN1SLC22A2
SCHEMBL8124337 0.91 CYP3A4 (0.52) CYP3A4CA2CTSDMEN1SLC22A2
SCHEMBL7297163 0.91 CYP3A4 (0.57) CYP3A4CA2MEN1SLC22A2SLC22A1
SCHEMBL7307494 0.91 CYP3A4 (0.51) CYP3A4CA2CTSDMEN1SLC22A2
SCHEMBL7300158 0.90 CA2 (0.62) CYP3A4CA2CTSDMEN1SLC22A2
SCHEMBL7357618 0.90 CYP3A4 (0.64) CYP3A4MEN1SLC22A2SLC22A1ABCC3
SCHEMBL6446319 0.89 CTSD (0.63) CYP3A4CA2CTSDCYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0486948-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 2000-10-04 EP disclosed
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5597926-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-01-28 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed